
    
      Subjects (n=48) with clinically diagnosed acute bacterial rhinosinusitis (ABRS)will included.
      The antibiotic group will receive amoxicillin (500 mg) 3 times per day for 10 days. The
      ultrasound group will receive therapeutic ultrasound over sinuses at 1.0 W/cm2 in continuous
      mode for 10 minutes once a day for 4 consecutive days. Improvement of symptoms (pain and
      congestion; numeric rating scale; 0-10) from day 1 to days 4 and 21 will be recorded.
      Relapses, side-effects and satisfaction with treatment will be assessed at one-year
      follow-up.
    
  